JPS6314693A - Plant virus RNA vector - Google Patents
Plant virus RNA vectorInfo
- Publication number
- JPS6314693A JPS6314693A JP61158443A JP15844386A JPS6314693A JP S6314693 A JPS6314693 A JP S6314693A JP 61158443 A JP61158443 A JP 61158443A JP 15844386 A JP15844386 A JP 15844386A JP S6314693 A JPS6314693 A JP S6314693A
- Authority
- JP
- Japan
- Prior art keywords
- rna
- transcription
- vector
- cdna
- coat protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013598 vector Substances 0.000 title claims description 55
- 241000700605 Viruses Species 0.000 title claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 47
- 230000035897 transcription Effects 0.000 claims description 41
- 238000013518 transcription Methods 0.000 claims description 41
- 239000002299 complementary DNA Substances 0.000 claims description 31
- 101710132601 Capsid protein Proteins 0.000 claims description 28
- 101710094648 Coat protein Proteins 0.000 claims description 28
- 101710125418 Major capsid protein Proteins 0.000 claims description 28
- 101710141454 Nucleoprotein Proteins 0.000 claims description 28
- 101710083689 Probable capsid protein Proteins 0.000 claims description 28
- 241000723848 Tobamovirus Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 108091008146 restriction endonucleases Proteins 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 238000003776 cleavage reaction Methods 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 230000007017 scission Effects 0.000 claims description 6
- 239000003550 marker Substances 0.000 claims description 4
- 230000010076 replication Effects 0.000 claims description 4
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 230000005026 transcription initiation Effects 0.000 claims description 3
- 241000701959 Escherichia virus Lambda Species 0.000 claims 1
- 108020005089 Plant RNA Proteins 0.000 claims 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 32
- 239000012634 fragment Substances 0.000 description 28
- 241000196324 Embryophyta Species 0.000 description 21
- 241000723873 Tobacco mosaic virus Species 0.000 description 18
- 238000010276 construction Methods 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 241000227653 Lycopersicon Species 0.000 description 7
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000208125 Nicotiana Species 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108091023045 Untranslated Region Proteins 0.000 description 4
- 241000219977 Vigna Species 0.000 description 4
- 235000010726 Vigna sinensis Nutrition 0.000 description 4
- 108020000999 Viral RNA Proteins 0.000 description 4
- 101150055766 cat gene Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000004594 DNA Polymerase I Human genes 0.000 description 3
- 108010017826 DNA Polymerase I Proteins 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 102000013165 exonuclease Human genes 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000009849 Cucumis sativus Nutrition 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101100020663 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ppm-1 gene Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- XKTYXVDYIKIYJP-UHFFFAOYSA-N 3h-dioxole Chemical compound C1OOC=C1 XKTYXVDYIKIYJP-UHFFFAOYSA-N 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 241000723845 Cucumber green mottle mosaic virus Species 0.000 description 1
- 244000308744 Cucumis dipsaceus Species 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001288713 Escherichia coli MC1061 Species 0.000 description 1
- 241000627377 Eucomis mosaic virus Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241001672648 Vieira Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- RBAMFWWUJRFUPC-CHWSQXEVSA-N [(2r,3r)-3-acetyloxy-2-[(2,2-dichloroacetyl)amino]-3-(4-nitrophenyl)propyl] acetate Chemical compound CC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](OC(C)=O)C1=CC=C([N+]([O-])=O)C=C1 RBAMFWWUJRFUPC-CHWSQXEVSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- VVOIFRARHIZCJD-GHMZBOCLSA-N chloramphenicol 3-acetate Chemical compound CC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 VVOIFRARHIZCJD-GHMZBOCLSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- PKUBDVAOXLEWBF-UHFFFAOYSA-N n-[1-(4-acetylphenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide Chemical compound CC(=O)C1=CC=C(C(O)C(CO)NC(=O)C(Cl)Cl)C=C1 PKUBDVAOXLEWBF-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 108091007054 readthrough proteins Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、植物ウィルスRN A−ベクター、該RNA
ベクター製造用転写・ベクターお、1、びこれらの製造
法並びに植物細胞への外来遺伝子の導入方法に関する。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to plant viral RNA vectors,
This invention relates to transcription vectors for producing vectors, vectors 1 and 1, methods for producing these, and methods for introducing foreign genes into plant cells.
・従来技術
トバモウイルス(tobamovi rus)は、タバ
コ、トマト、ササゲ、キュウリ等の植物から分離される
棒状RNAウィルスであり、タバコ、トマト等を宿主と
するタバコモザイクウィルス(TMV)及びキュウリ等
を宿主Aするキュウリ緑斑モザイクウィルス(CGMM
V)等がこれに属する。・Prior art Tobamovirus is a rod-shaped RNA virus isolated from plants such as tobacco, tomatoes, cowpeas, and cucumbers.Tobacco mosaic virus (TMV), which uses tobacco and tomatoes as hosts, and cucumbers, etc., as hosts A. cucumber green spot mosaic virus (CGMM)
V) etc. belong to this category.
TMVは、タバコから単離された普通系、トマト、ササ
ゲから単離されたトマト系やササゲ系等の数種類がある
ことが知られている。It is known that there are several types of TMV, such as a common type isolated from tobacco, a tomato type and a cowpea type isolated from tomatoes and cowpeas.
すでに、トマト系T、MV−L株やその弱毒株TMV−
LIIA株等の数種類のトバモウイルスの塩基配列が決
定され、報告されている(例えば、NishiN15h
i et al、: Nucleic、 Ac1ds
Res、 13゜5585 (1985);開田:細胞
工学Vo1.4. No、11. P、979−990
(19’85) ”)。Already, tomato T and MV-L strains and its attenuated strain TMV-
The nucleotide sequences of several types of tobamoviruses such as the LIIA strain have been determined and reported (for example, NishiN15h
i et al: Nucleic, Ac1ds
Res, 13°5585 (1985); Kaida: Cell Engineering Vol. 1.4. No, 11. P, 979-990
(19'85)").
また、TMV−L株およびTMV−L、、A株RNAの
完全長cDNAを作成し、これをアールキスト(Ahl
quist)らの開発した転写ベクターpPM1へクロ
ーニングし、これを線状化した後、大腸菌のRNAポリ
メラーゼでインビトロ転写反応を行い感染性TMV−R
NAを再生することに成功している。In addition, we created full-length cDNA of TMV-L strain and TMV-L, A strain RNA, and used it with Ahlquist (Ahlquist).
After cloning into the transcription vector pPM1 developed by E.
Successfully regenerated NA.
本発明らは、1〜バモウイルスRNAを植物細胞の形質
転換に用いる植物ベクターに利用する目的で更に研究を
進め、本発明を完成した。The present inventors further conducted research for the purpose of utilizing vamovirus RNA as a plant vector for use in transforming plant cells, and completed the present invention.
発明の概要
本発明は、植物細胞への外来遺伝子の導入に用いるRN
Aベクター、該1’?NAベクターの製造用転写ベクタ
ーおよびこれらを製造する方法および植物細胞への外来
遺伝子の導入方法を提供する。Summary of the Invention The present invention provides an RN for use in introducing foreign genes into plant cells.
A vector, said 1'? Provided are transcription vectors for producing NA vectors, methods for producing them, and methods for introducing foreign genes into plant cells.
発明の詳細な説明
本発明のRNAベクターは、I・ハモウィルスのコート
タンパク遺伝−j’pfl域を所望の外来遺伝子で置換
することにより製造することができる。DETAILED DESCRIPTION OF THE INVENTION The RNA vector of the present invention can be produced by replacing the coat protein gene-j'pfl region of I. hamovirus with a desired foreign gene.
トバモウイルスのゲノムには、ウィルス複製に関与して
いるタンパクであるとtll、定されている2種類のタ
ンパク、30にタンパクおよびコートタンパクの4種類
のタンパクがコードされていることが知られており、T
MVについて言えば、130にタンパクおよびそのリー
ドスルータンパクである180にタンパク、30にタン
パクおよびコートタンパクの4種類の遺伝子から成り立
っていることが知られている。 本発明のRNAベクタ
ーは、このコートタンパクをコードする遺伝子領域を外
来遺伝子で置換することにより製造することができる。It is known that the tobamovirus genome encodes four types of proteins: two types of proteins, which have been identified as tll, which are involved in virus replication, a 30-year-old protein, and a coat protein. , T
Regarding MV, it is known that it consists of four types of genes: protein 130 and its read-through protein 180, protein 30, and coat protein. The RNA vector of the present invention can be produced by replacing the gene region encoding this coat protein with a foreign gene.
このRNAベクターの製造は、以下の工程により実施す
ることができる。This RNA vector can be produced by the following steps.
1)ウィルスRNAの完全長cDNAを合成2)ウィル
スRNAの完全長cDNAのコートタンパクをコードす
る領域が外来遺伝子で置換された完全長の組み換えcD
NAを含む転写ベクターを構築
3)上記の転写ベクターを線状化
4)線状化された転写ベクターを常法によりRNAポリ
メラーゼによる転写反応を行い、目的の組み換えRNA
ベクターを製造する。1) Synthesis of full-length cDNA of viral RNA 2) Full-length recombinant cD in which the coat protein coding region of full-length cDNA of viral RNA is replaced with a foreign gene
Construction of a transcription vector containing NA 3) Linearize the above transcription vector 4) Perform a transcription reaction using RNA polymerase on the linearized transcription vector by a conventional method to obtain the desired recombinant RNA.
Manufacture the vector.
この際、m ’ G ppp Gの存在下にRN Aポ
リメラーゼにより転写反応を行い、RN Aの5゛末端
をキャップ構造でブロックした場合には、植物細胞への
組み換えRNAの感染性が顕著に増大するが、RNAの
5゛末端をキャンプ構造でブロックすることは必須では
ない。 また、RNAの3゛末端については、3゛末端
を越えて多くのヌクレオチドが接続してないことが望ま
しく、転写ベクターによるcDNAからのRNAの転写
に際し、RNAの3゛末端で正illに転ffj゛が終
了することが望ましい。 この為に、鋳型となるcDN
A3”末端の直近に適当な制限酵素(例えば、M l
u T )による切断部位を組め込み、転写の前に、そ
こでcDNAを切断することにより転写を停止させるこ
とが望ましい。At this time, if the transcription reaction is performed with RNA polymerase in the presence of m'G ppp G and the 5' end of the RNA is blocked with a cap structure, the infectivity of the recombinant RNA to plant cells increases markedly. However, it is not essential to block the 5' end of the RNA with a camp structure. Furthermore, regarding the 3' end of RNA, it is desirable that many nucleotides not be connected beyond the 3' end, so that when transcribing RNA from cDNA using a transcription vector, the 3' end of the RNA is transferred to the positive ill. It is desirable that ゛ be completed. For this purpose, cDNA as a template is
Insert an appropriate restriction enzyme (e.g., M
It is desirable to incorporate a cleavage site by u T ) and terminate transcription by cleaving the cDNA there prior to transcription.
上述の転写ベクターとしては、複製開始領域、選択マー
カー、プロモーターおよび転写開始点の直後に鋳型とな
るDNAの挿入部位および挿入されたDNAのすぐ下流
に制限酵素切断部位を有するすでに公知の転写・ベクタ
ーを用いることができる。 例えば、アールキスト(A
hlquist)の開発したpPMl等(本ベクターに
関しアグリジエネテイクス リサーチ アソシエイツ
リミテッドが特許出願:公開特許公報 昭和61年57
79号を出願しており、本ベクターを業として使用する
場合は、権利者の承諾を必要とする。本願発明に至る実
験において、アールキスト氏から提供されたpPMlを
用いた。)の公知の転写ベクターを用いることができる
。The above-mentioned transcription vectors include already known transcription vectors that have a replication initiation region, a selection marker, a promoter, a template DNA insertion site immediately after the transcription initiation site, and a restriction enzyme cleavage site immediately downstream of the inserted DNA. can be used. For example, Ahlquist (A
pPMl etc. (this vector was developed by AgriGenetics Research Associates)
Limited filed a patent application: Published Patent Publication 1986 57
No. 79 has been filed, and if this vector is to be used commercially, the consent of the right holder is required. In the experiments leading to the present invention, pPMl provided by Mr. Ahlquist was used. ) can be used.
pPMlは、転写が挿入したcDNAの一番端から開始
し、RNAの3゛末端に相当する部分に制限酵素部位を
有し、この部位で切断し線状化後、転写することにより
ウィルスRNAの3”末端をこえて感染性に影響を与え
る程度の余分なヌクレオチドを接続しないように工夫さ
れた転写用ベクターである。In pPMl, transcription starts from the very end of the inserted cDNA, and it has a restriction enzyme site at the part corresponding to the 3' end of the RNA. It cuts at this site, linearizes it, and then transcribes the virus RNA. This is a transcription vector designed to avoid connecting extra nucleotides beyond the 3'' end that would affect infectivity.
本発明において、ベクターとして使用するトバモウイル
スとしては、トマト系、普通系、ササゲ系等のTMVお
よびCGMMVを用いることができる。 野生株および
植物に対し病徴を生じない感染性を示す自然度)°−株
あるいは組み換え技術により変異を生じさ−U弱毒化し
たものを用いることが可能である。In the present invention, tobamoviruses used as vectors include tomato-based, common-based, cowpea-based TMV and CGMMV. It is possible to use wild-type strains and strains that exhibit infectivity without causing disease symptoms or attenuated strains that have been mutated by recombinant technology.
ウィルスRNへの完全14のc I) N Aは、逆転
写酵素でRNAを逆転7ノ°する公知の方法で容易に作
成することができる。 例えば、1’ M V −L株
のゲノムRNA (1〜(7215番11)のcDN、
Aおよび3°末端1’、6KbのcDNA、並びにTM
V、L++A株の完全長c、 I) N Aをクローニ
ングしたプラスミドp L T −1) 27、 p
L−1−13およびpL++A A25などが公知で
あり、それぞれ0hno etal、:J、旧oche
m、りfi、 1915−1923(1984) 、
Takamastu cl al、:Nucl e
ic Ac1ds Res、 11.3767−3
778(1983) 、およびNishiguN15h
i al、 :Nucleic Ac1ds Res、
13.5585−5590(1985)に記載の方法
で製造できる。A complete 14 c I) NA to viral RNA can be easily created by a known method of inverting the RNA 7 times with reverse transcriptase. For example, the genomic RNA of the 1' MV-L strain (cDNA of 1 to (7215 No. 11),
A and 3° end 1', 6 Kb cDNA, and TM
V, L++A strain full-length c, I) Plasmid pLT-1) cloned with NA 27, p
L-1-13 and pL++A A25 are known, respectively.
m, Rifi, 1915-1923 (1984),
Takamastucl al, :Nucle
ic Ac1ds Res, 11.3767-3
778 (1983), and NishiguN15h
ial, : Nucleic Ac1ds Res,
13.5585-5590 (1985).
本発明のRNAベクターの製造に鋳型として用いられる
DNAは、ウィルスT?NAの完全長cDNAのコート
タンパクの遺伝子1irf域を外来遺伝子DN、Aで置
換したI) N Aを転写ベクターに組み込むことによ
り製造されるが、この組み換え転写ベクター自体の構築
は、遺伝子組み換えで用いられる常法を用いることによ
り行うことができる。The DNA used as a template for producing the RNA vector of the present invention is virus T? I) The gene 1irf region of the coat protein of the full-length NA cDNA is replaced with a foreign gene DNA, A.It is produced by incorporating NA into a transcription vector, but the construction of this recombinant transcription vector itself requires genetic recombination. This can be done by using a conventional method.
特に、第2図に示した転写ベクターpLDC329の如
くトバモウイルスRNAのcDNAのコートタンパク遺
伝子領域を除去し、この部分に外来遺伝子の挿入を可能
にする制限酵素切断部位を導入することにより構築した
複製開始領域、選択マーカー、プロモーターおよびコー
トタンパク遺伝子領域が外来遺伝子挿入のための制限酵
素切断部位へ変換された配列のトバモウィルスRNAの
cDNAから成り、該プロモーターの転写開始ヌクレオ
チドが該cDNAの最初のヌクレオチドであるように接
続されているユニバーサル転写ベクターを用いることに
より容易に行うことができる。In particular, a replication vector constructed by removing the coat protein gene region of the tobamovirus RNA cDNA and introducing a restriction enzyme cleavage site that enables insertion of a foreign gene into this region, such as the transcription vector pLDC329 shown in Figure 2, is constructed. It consists of a cDNA of tobamovirus RNA in which the region, selection marker, promoter, and coat protein gene region have been converted into restriction enzyme cleavage sites for foreign gene insertion, and the transcription initiation nucleotide of the promoter is the first nucleotide of the cDNA. This can be easily done by using a universal transcription vector that is connected as follows.
このユニバーサル転写ベクターの外来遺伝子挿入部位に
所望の遺伝子を通常の遺伝子組み換え技術を用い挿入す
ることにより目的とする転写ベクターを構築することが
できる。A desired transcription vector can be constructed by inserting a desired gene into the foreign gene insertion site of this universal transcription vector using conventional genetic recombination techniques.
本発明により植物細胞へ導入される遺伝子としては、特
に限定されるものではないが、例えば、高温や低温に対
する耐性を改善する遺伝子、霜、害虫、病原微生物、ウ
ィルス等に対する耐性を改善する遺伝子、除草剤に対す
る耐性を改善する遺伝子、植物の成長に関与する遺伝子
、窒素固定化に関与する酵素等、光合成に関Jjする遺
伝子、植物の栄養上の特性や風味に関ずろ遺伝子、有用
物質の遺伝子など種々の遺伝子が挙げられる。Genes introduced into plant cells according to the present invention are not particularly limited, but include, for example, genes that improve resistance to high and low temperatures, genes that improve resistance to frost, pests, pathogenic microorganisms, viruses, etc. Genes that improve tolerance to herbicides, genes involved in plant growth, enzymes involved in nitrogen fixation, genes related to photosynthesis, genes related to nutritional characteristics and flavor of plants, genes for useful substances Various genes can be mentioned.
植物細胞の形質転換&、l: 、1.述のようにして作
成した組み換えRNΔベクターを植物細胞へ感染させる
ことにより行うことができる。 この際、ウィルスのコ
ートタンパクを用いウィルスの再構成を行った後に、植
物−・接種!l−るごとにより植物細胞へ感染させるこ
とに、1、す、感梁率を増大させることができる。 植
物細11;シへの感染は、再構成反応液を必要に応じ水
、緩衝液等で適゛1′Iな濃度へ希釈後、あるいはウィ
ルスまたはI’? N Aを緩衝液等で懸濁しカーボラ
ンダJ、と共に植物・\接種することにより行うことに
より容易に行うことができる。Transformation of plant cells &,l: ,1. This can be carried out by infecting plant cells with the recombinant RNAΔ vector created as described above. At this time, the virus is reconstituted using the virus coat protein, and then the plants are inoculated! By infecting plant cells with the same method, the sensitivity can be increased. Infection of plants is carried out by diluting the reconstituted reaction solution with water, buffer, etc. as necessary to an appropriate concentration, or by infecting viruses or I'? This can be easily carried out by suspending NA in a buffer solution or the like and inoculating the plant together with Carbolanda J.
対象となる植物とし“ζは、例えば、タバコやトマド等
のトバモウイルスが感染しうるちのであればよく、特に
制限はない。The target plant "ζ" is not particularly limited as long as it is a plant that can be infected with tobamovirus, such as tobacco or tomato.
以下に実施例を挙げ本発明を更に詳細に説明する。The present invention will be explained in more detail with reference to Examples below.
本発明は、この実施例にのみ限定されるものではなく、
本発明の技術分野において通常なされる変更および改良
を含むものである。The present invention is not limited only to this example,
It is intended to include modifications and improvements commonly occurring in the art to which the invention pertains.
RNAベクターのcDNAの構築
TMVのコートタンパク遺伝子領域を外来遺伝子で置換
したcDNAを含む組み換えcDNAを以下のように製
造した。Construction of cDNA of RNA Vector A recombinant cDNA containing a cDNA in which the coat protein gene region of TMV was replaced with a foreign gene was produced as follows.
なお、本実施例においてDNAのクローニングには、大
腸菌H8101株を用いた。In this example, E. coli strain H8101 was used for DNA cloning.
■)完全長のクロラムフェニコール アセチルトランス
フェラーゼ(chloramphenicol ace
tyltransferase : CA T )遺伝
子を含むプラスミドp B R325(F、Boliv
ar、 Gene 4,121 (197B) )か
らBan1フラグメントを切出し、大腸菌DNAポリメ
ラーゼIのクレノー(KlenolII)フラグメント
を用いフィルインした後、5au3AIで消化すること
により0.74Kbフィルド−イン+13 a n I
/ S a u 3 A Iフラグメン(CATの全
コード領域、 59bpの5゛非翻訳領域および24b
pの3°非翻訳領域を含む)を単離した。■) Full-length chloramphenicol acetyltransferase
Plasmid pBR325 (F, Boliv) containing the tyltransferase: CAT) gene
ar, Gene 4,121 (197B)), filled in using the Klenol II fragment of E. coli DNA polymerase I, and digested with 5au3AI to create a 0.74 Kb filled-in + 13 a n I.
/ S au 3 A I fragment (entire coding region of CAT, 59 bp of 5' untranslated region and 24 b
(including the 3° untranslated region of p) was isolated.
転写ベクターpl)、Mlへ′I″MV−Lの完全長c
DNAを組み込んだ公知の転写ベクターpLFW3 (
石川ら: 第11川11本分子生物学会年会(1985
))をA V ;J I+で消化し1” M V −1
−のゲノムRNAの61fliO化+1に相当する個所
で切断し、クレノー(KIcnc++u)フラグメント
を用いフィルインした後、更にi’ M Vのr、 l
) NΔの4bpT流において3allで消化すること
によりTMVの3゛末端部分および:I−1タンパク遺
伝子の22bpを含む0 、2 :(’I< bの)2
fルド−インAvall/5allDNA断片を得た。Transcription vector pl), full-length c of 'I''MV-L into Ml
A known transcription vector pLFW3 incorporating DNA (
Ishikawa et al.: 11th Annual Meeting of the Molecular Biology Society (1985)
)) was digested with AV;
- genomic RNA was cut at a site corresponding to 61fliO-ylation +1, and filled in using a Klenow (KIcnc++u) fragment, and then r, l of i' MV
) 0,2:('I<b)2 containing the 3' terminal part of TMV and 22 bp of the I-1 protein gene by digesting with 3all in the 4bp T stream of NΔ
A f domain Avall/5all DNA fragment was obtained.
これらの2フラグメントを結合後、p1目ン322の
13 a m HIと5allザイlの間にりu −=
7グし、pCAT3L−10を構築した。After joining these two fragments, u −=
pCAT3L-10 was constructed.
pcAT31、−IOをp BI? 322由来のEc
oRVサイトで切断し、 綿状化した後、Ba131エ
キソヌクレアーゼで< 0.6Ml 1−
NaCl、20mMTr 1s−HCj! (pH8
) 、12mM MgCj!、、 12mM C
aCj!2.11.6μgpCAT3L−to /gc
、oRV、2.6’uBa131エキソヌクレアーゼを
含む反応液中、30℃、7,5分間反応”)CAT遺伝
子の開始コドンの近くまで切り詰めた。pcAT31, -IO pBI? Ec derived from 322
After cutting at the oRV site and flocculization, <0.6 Ml 1-NaCl, 20mM Tr 1s-HCj! with Ba131 exonuclease. (pH8
), 12mM MgCj! ,, 12mM C
aCj! 2.11.6μgpCAT3L-to/gc
, oRV, and 2.6'uBa131 exonuclease at 30° C. for 7.5 minutes.
これに5acIリンカ−(1)dCGAGCTCG)を
接続し、5aclおよび5allで消化した後、CAT
遺伝子およびTMVの全3゛非翻訳領域を含むDNA−
t−pUCl 8の5aCIおよび5allサイトの間
にクローニングした。 結合反応液を用いE、coli
HBlolを形質転換し、アンピシリンおよびクロラム
フェニコールに耐性のコロニーからプラスミドを単離し
た。A 5acI linker (1) dCGAGCTCG) was connected to this, and after digestion with 5acl and 5all, CAT
DNA containing the gene and all 3 untranslated regions of TMV-
It was cloned between the 5aCI and 5all sites of t-pUCl 8. Using the binding reaction solution, E. coli
HBLol was transformed and plasmids were isolated from colonies resistant to ampicillin and chloramphenicol.
グイデオキシ法でDNA配列を決定し、1obpの5゛
リーダー領域を゛含むCAT遺伝子およびTMVの3
゛末端およびコートタンパクの一部を含むptC3L″
5−2・を選択した。The DNA sequence was determined by the guideoxy method, and the CAT gene containing the 1 obp 5' leader region and 3 of TMV were sequenced.
``ptC3L containing the terminal end and part of the coat protein''
5-2. was selected.
一方、p 、L F W 3コートタンパク遺伝子領域
中(7)BstEIrサイト(TMVゲノムRNAの5
799番目に相当する部位))で消化し、 Ba131
エキソヌクレアーゼで(0,6MNa’Cp220mM
Tr i 5−HC7! (pl+8.0) 、12m
M M g C7!t、l 2mMCaCj!z 、
10.ljgP L F W 3 / Tl s L
l’: Tl、1.3uBa 131mmキスクレアー
ゼを含む反応液中、30℃、3分間反応)コートタンパ
ク遺伝子の開始コドンの近くまで切り詰めた。 これに
S 、J(二[リンカ−を接続した後、Sa c’ l
およびK p n T’ (TMVゲノムの4390番
口に相当する部位)で消化した。On the other hand, p, LFW 3 coat protein gene region (7) BstEIr site (TMV genomic RNA 5
Digested at the site corresponding to position 799)), Ba131
With exonuclease (0,6M Na'Cp220mM
Tri 5-HC7! (pl+8.0), 12m
M M g C7! t,l 2mMCaCj! z,
10. ljgP L F W 3 / Tl s L
l': Tl, 1.3 uBa 131 mm Reacted at 30° C. for 3 minutes in a reaction solution containing kiss crease) It was truncated to the vicinity of the start codon of the coat protein gene. To this, S, J (2[After connecting the linker, Sac' l
and K p n T' (a site corresponding to opening 4390 of the TMV genome).
コートタンパクの上流を含む1.25〜1.35Kbの
S a c I / K p n Iフラグメントをp
U’C18のSac■およびに’pn!リーイトの間に
クローニングした。 上記と同様に大腸菌を形質転換後
、プラスミドを単離、1.) N A配列を決定し、T
MVの30にタンパク遺伝子、180にタンパク遺伝子
の一部およびコートタンパク遺伝子A’TGに続く4b
pを含むpt5L29を′選択した。A 1.25-1.35 Kb Sac I/K pn I fragment containing upstream of the coat protein was
U'C18's Sac■ and ni'pn! Cloned during the leak. After transforming E. coli in the same manner as above, isolate the plasmid, 1. ) Determine the NA sequence and T
Protein gene at 30 of MV, part of the protein gene at 180, and 4b following coat protein gene A'TG
pt5L29 containing p was selected.
pCL29の構築:
pt5L29の1.32Kbの5acI/Kpnlフラ
グメント(180にタンパク遺伝子の一部、30にり、
ンパク遺伝子およびコートタンパク遺伝子の開始コドン
およびその下流4bpを含む)、p tc3L5−2の
0.963Kbの5acl/M I u Iフラグメン
ト(CAT遺伝子およびその上流10bp並びにTMV
の3゛末端領域を含む)およびpLFW3のKpnl/
Mlulフラグメントを結合しpCL29を構築した。Construction of pCL29: 1.32 Kb 5acI/Kpnl fragment of pt5L29 (part of the protein gene at 180, part of the protein gene at 30,
protein gene and coat protein gene (including the start codon and 4 bp downstream thereof), a 0.963 Kb 5 acl/M I u I fragment of ptc3L5-2 (including the CAT gene and 10 bp upstream thereof, and TMV
) and Kpnl/ of pLFW3
The Mlul fragment was ligated to construct pCL29.
このpCL29は、pLFW3のTMVコートプロティ
ン遺伝子領域をCAT遺伝子で置換された構造を有する
。This pCL29 has a structure in which the TMV coat protein gene region of pLFW3 is replaced with the CAT gene.
p CL B 29の構築:
pt5L29の5acl/Kpnlフラグメントおよび
p tC3L5−2の5acI/M1uIフラグメント
の5aclサイトをクレノーフラグメントでフィルアウ
トし平滑末端とした後、pCL29構築と同様に結合し
p CLB 29を構築した。Construction of pCLB 29: The 5acl sites of the 5acl/Kpnl fragment of pt5L29 and the 5acI/M1uI fragment of ptC3L5-2 were filled out with Klenow fragment to make blunt ends, and then ligated in the same manner as for pCL29 construction. was built.
ユニバーサル転写ベクターpLDC329の構築:コー
トタンパク遺伝子領域を除去し、この部分に外来遺伝子
の挿入を可能にする制限酵素切断部位(Sacl)を導
入したユニバーザル転写ベクターpLDcs29を以下
のように、構築した。Construction of universal transcription vector pLDC329: Universal transcription vector pLDcs29 was constructed as follows, in which the coat protein gene region was removed and a restriction enzyme cleavage site (Sacl) was introduced into this region to enable insertion of a foreign gene.
pLFW3をA V a IIで消化、クレノーフラグ
メントでフィルインした後、3 a c、 lリンカ−
を接続し、5aclおよびM l u Iで消化し、0
.23Kbの5acl/Mlulフラグメント(TMV
の3゛非翻訳領域およびコートタンパクのC末端22b
pを含む)を単離した。After digesting pLFW3 with A Va II and filling in with Klenow fragment, 3 a c, l linker
connected, digested with 5acl and M l u I, 0
.. 23Kb 5acl/Mlul fragment (TMV
3゛untranslated region and C-terminal 22b of coat protein
p) were isolated.
このSa c I/Ml uIフラグメントをpt5L
29から単離した1、32Kbの5acl/Kpnlフ
ラグメントおよびpL、FW3から単離したK p n
I / M 、1 u Iフラグメント(大きい方の
フラグメントを使用)と結合し、コートタンパク遺伝子
の5710−6160番目が除かれ5aclサイトを挿
入されたpLDcs29を構築した。This SacI/MluI fragment was converted into pt5L
1, 32 Kb 5acl/Kpnl fragment isolated from 29 and pL, Kpn isolated from FW3
I/M, 1 u I fragment (the larger fragment was used) to construct pLDcs29 in which positions 5710-6160 of the coat protein gene were removed and the 5acl site was inserted.
転写:
上記のように製造した転写ベクターpCL29、pCL
B29をM I IJ Iで消化後、大腸菌RNAポリ
メラーゼを用い公知法 (AI+1quist et
al。Transcription: Transcription vector pCL29, pCL produced as above
After digesting B29 with M I I J I, a known method (AI+1quist et al.
al.
Proc、 Natl、 Acad、 Sci、 ll
5A 01.7066−7070(1984)により転
写した。 得られたRNAをフェノール抽出およびエタ
ノール沈澱で精製した。Proc, Natl, Acad, Sci, ll
5A 01.7066-7070 (1984). The resulting RNA was purified by phenol extraction and ethanol precipitation.
これを公知の酢酸法(Fraenkel −Conra
t、H。This is carried out using the known acetic acid method (Fraenkel-Conra).
t, H.
Virology 4.1−4(1957))で精製し
たTMVの普通株のコートタンパク(4m g / m
j! )を用い0、!Mリン酸ナナトリウム緩衝液p
H7,0)中で20℃で16時間処理しウィルス粒子再
構成を行った。The coat protein of a common strain of TMV (4 mg/m
j! ) using 0,! M sodium phosphate buffer p
Virus particles were reconstituted by treatment in H7,0) at 20°C for 16 hours.
植物細胞への感染および発現:
上記のように再構築した反応液を緩衝液で5倍に希釈し
、N1cotiana tabacum Samsun
の葉に塗布した。 10日栽培した後、葉を採集し
抽出液(250mMTris−HCj! (pH7,5
)、2.5mM EDTA、0.1%アスコルビン酸
、0.5mMロイペプチン、1 mMPMsF)を加え
、磨砕し、60℃で10分間加温した。 遠心分離(1
4,000x g、5分)後、上清を緩衝液で10.0
μnとし5μlの10mMアセチルCoAおよび0.0
67μCiの14Cラベル−クロラムフェニコール(5
3mCi /mmo I ;アマシャム)と混合し37
℃で30分間インキュベートした。 クロラムフL二二
1−ルおよびその誘導体を酢酸エチルで抽出し、減圧下
に乾固した後、5μlの酢酸エチルに懸濁した。Infection and expression of plant cells: The reaction solution reconstituted as above was diluted 5 times with buffer solution, and N1cotiana tabacum Samsun
applied to the leaves. After 10 days of cultivation, the leaves were collected and extracted with an extract (250mM Tris-HCj! (pH 7,5
), 2.5mM EDTA, 0.1% ascorbic acid, 0.5mM leupeptin, 1mM PMsF) were added, ground, and heated at 60°C for 10 minutes. Centrifugation (1
After (4,000 x g, 5 min), the supernatant was diluted with buffer at 10.0
μn and 5 μl of 10 mM acetyl-CoA and 0.0
67 μCi of 14C-labeled chloramphenicol (5
3 mCi/mmo I; Amersham) and 37
Incubated at ℃ for 30 minutes. Chloramfluor L-221- and its derivatives were extracted with ethyl acetate, dried under reduced pressure, and then suspended in 5 μl of ethyl acetate.
このLPfi+液をクロロポルノ、/メタノール(95
:5)を溶媒としシリガゲル薄層り11マドグラフイー
にかけ、 クロラムソ丁−二ごI−)しおよびそのアセ
チル誘導体(lAccm:l アセチルクロラムフェ
ニコール、 3AcCr++:3−アセチルクロラムフ
ェニコール、 I、3AcCrrz l、3−ジアセ
チルクロラムフェニコール)をオートラジオグラフィー
(室温、16時間)により検出した。 結果を第6図に
示す。 この図中、レーンlは、未反応14 Cラヘル
−りロラムフェニコール(Cm) 、レーン、2は、転
回反応液を塗布してない対象植物の葉0.5mgの抽出
物、レーン3は野生株のTMVを感染させた植物の抽出
物、レーン4は、コートタンパク遺伝子を有しない転写
ベクターpLD、C329の転写産物、レーン5および
6は、pCL29およびpCLI329の転写塵物を塗
布した植物の抽出物のものである。 レーン7は、0.
03単位のCATの反応物のものである。This LPfi+ liquid was mixed with chloroporne/methanol (95
: 5) as a solvent and subjected to silica gel thin layer layer 11 madography, chloramsodic chloramphenicol I-) and its acetyl derivative (lAccm:l acetylchloramphenicol, 3AcCr++: 3-acetylchloramphenicol, I, 3AcCrrz 1,3-Diacetylchloramphenicol) was detected by autoradiography (room temperature, 16 hours). The results are shown in Figure 6. In this figure, lane 1 is unreacted 14C-raherylloramphenicol (Cm), lane 2 is an extract of 0.5 mg of leaves of the target plant to which the rotation reaction solution has not been applied, and lane 3 is Lane 4 is the transcript of the transcription vector pLD, C329, which does not have the coat protein gene. Lanes 5 and 6 are the extract of the plant infected with the wild-type TMV. It is an extract. Lane 7 is 0.
03 units of CAT reactant.
この結果から明らかなように、pCL29およびpCL
B29によるCATの発現が確認された。As is clear from this result, pCL29 and pCL
Expression of CAT by B29 was confirmed.
参考例
完全長のTMV−LのcDNAを含む転写ベクターpL
FW3の構築:
TMV−RNAの完全長cDNAの合成1)TMV−L
株あるいは弱毒株L++Aをタバコに接種し増殖させた
。 感染されたタバコを磨砕後、ウィルス粒子を公知の
方法で精製し、次いでウィルス粒子からRNAを公知法
(TakaIIatu et訂、Nucleic Ac
1ds Res、 11.3767−3778 (19
83))で精製した。このRNAを過剰の合成プライマ
ー (TMV−RNAの3°末端の18残基に相補的な
配列を有する。或いは、必要に応じ、 3゜末端の第9
番目に相当するAをTに変換したものを使用)とアニー
ルした。 このアニールしたRNAを用い、50 II
l: / m’ 1.のアニールRNAおよび250
単位/ m Iの逆転′す°酵素を含む反応液を調製、
これを42℃、90分間反応しc DNAを合成した。Reference example: Transcription vector pL containing full-length TMV-L cDNA
Construction of FW3: Synthesis of full-length cDNA of TMV-RNA 1) TMV-L
The strain or attenuated strain L++A was inoculated into tobacco plants and allowed to grow. After grinding the infected tobacco, virus particles were purified by a known method, and then RNA was extracted from the virus particles by a known method (edited by Taka II Atu et al., Nucleic Ac
1ds Res, 11.3767-3778 (19
83)). This RNA was combined with an excess of synthetic primers (having a sequence complementary to the 18 residues at the 3° end of TMV-RNA; or, if necessary, the 9th residue at the 3° end).
(using the A corresponding to the th A converted to T) and annealing was performed. Using this annealed RNA, 50 II
l: / m' 1. annealed RNA and 250
Inversion of units/mI'°Prepare a reaction solution containing the enzyme,
This was reacted at 42°C for 90 minutes to synthesize cDNA.
フェノール抽出、エタノール沈澱によりDNAを回収後
、+1 、1 N N ’a OHによりRNAを分解
した。 これを5〜20% アルカリ−ショ糖密度勾配
遠心あるいは2.5%ポリアクリルアミド/8.3M尿
素ゲル電気泳動にかけ完全長のRNAに相当するcDN
Aを分取した。After recovering DNA by phenol extraction and ethanol precipitation, RNA was degraded with +1 and 1 N N'a OH. This was subjected to 5-20% alkaline-sucrose density gradient centrifugation or 2.5% polyacrylamide/8.3M urea gel electrophoresis to obtain cDNA corresponding to full-length RNA.
A was collected.
上記のように合成した完全長cD’NAに過剰の合成プ
ライマー(TMV−4Nへの1〜19残基に相当する配
列を有する)を加え! OmMTr i 5−HCI
(p H7,5) 、 I O’mMMg
C1z 、50mMNaCρ中で、90℃で5分間加熱
した後、徐々に冷却しアニールした。Add excess synthetic primer (having a sequence corresponding to residues 1 to 19 to TMV-4N) to the full-length cD'NA synthesized as above! OmMTr i 5-HCI
(pH 7,5), IO'mMMg
After heating at 90°C for 5 minutes in C1z and 50mM NaCρ, the sample was gradually cooled and annealed.
このcDNAを1 tlmMTr i 5−HCI!、
(1)’H7’、5) 、2’5mM NaC7,1
0rr+MM g C12,5mMジ千オスレイ1−ル
、0.2mMの各d N T P中で250中位/m7
!の大腸菌DN−Aポリメラーゼ1ラージフラグメント
を加え21 ”Cで3時間反応し二本鎖cDNAに変換
した。This cDNA was injected into 1 tlmMTri 5-HCI! ,
(1)'H7', 5), 2'5mM NaC7,1
0rr + MM g C12, 5mM dioxole, 0.2mM each dNTP at 250 medium/m7
! E. coli DNA-A polymerase 1 large fragment was added thereto and reacted at 21''C for 3 hours to convert into double-stranded cDNA.
低融点アガロースゲルにより精製し完全長の二本鎖cD
NAを得た。Full-length double-stranded cD purified by low melting point agarose gel
Got NA.
完全長cDNAのクローニング
pUcG’J1の構築
pUC9のポリリンカー配列部位にMlulサイトを導
入するために、p C09F 2 (Mesi eta
l、 Virology 127.54−64 (19
83) ; cucombergreen mottl
e mosaic virus のM l u Iサ
イトを含む約1.6Kbを含む)のQ、21 K bの
HindllI/フィル−インM l u Iフラグメ
ントをpU C9(Vieira et al、 Ge
ne 19.259−268 (19B2)のl(i
n d [7/フィルーイン5allサイトへ挿入しp
UcG91を構築した。Cloning of full-length cDNA Construction of pUcG'J1 In order to introduce a Mlul site into the polylinker sequence site of pUC9, pC09F 2 (Mesi et al.
l, Virology 127.54-64 (19
83); cucombergreen mottl
The 21 Kb HindllI/Fill-in Mlu I fragment of Q, which contains approximately 1.6 Kb containing the Mlu I site of E. mosaic virus, was transformed into pU C9 (Vieira et al,
ne 19.259-268 (19B2) l(i
n d [7/Fill-in 5all site insert p
UcG91 was constructed.
pUCG91のM I u Iサイト周辺の構造を第5
図にしめす。The structure around the M I u I site of pUCG91 is
Shown in the diagram.
TM’V=L株の完全長c’ D N Aを含むプラス
ミドpLFWlの構築
1)pLM51およびpLM31の構築上記のようにし
て得られた完全長二本鎖cDN2l−
=20 =
A (TMV−L株)をB g I IIで消化し、R
NAの5°末端部分に相当する2、62Kbを得た後、
精製した。Construction of plasmid pLFWl containing full-length c' DNA of TM'V=L strain 1) Construction of pLM51 and pLM31 Full-length double-stranded cDN obtained as above 2l- = 20 = A (TMV-L strain) was digested with B g I II and R
After obtaining 2,62 Kb corresponding to the 5° terminal part of NA,
Purified.
これをp’P’M1のPmプロモーターを含む3.03
KbのAatTI/SmalフラグメントおよびpUC
9の0.47 K bのAaLn/BamHIフラグメ
ントと結合した。 結合したDNAをE、 c
o I iMcl 0 6 1 (Casdr
laban et al、:J9Mo1. Bio
l、 138.17’9−207 (1980) )
ヘ形質転換した。 コロニーハイプリダイジョンおよ
び制限酵素地図を作成し、第4図に示した構造のpLM
5’lを゛含む大腸菌を選択した゛。3.03 containing the Pm promoter of p'P'M1
AatTI/Smal fragment of Kb and pUC
9 and a 0.47 Kb AaLn/BamHI fragment. The combined DNA is E, c
o I iMcl 0 6 1 (Casdr
laban et al.: J9Mo1. Bio
l, 138.17'9-207 (1980))
transformed into Colony hybridization and restriction enzyme maps were created, and pLM with the structure shown in Figure 4 was created.
E. coli containing 5'l was selected.
2)pLM31の構築
上記のようにしてjitられた完全長二本鎖cDNA(
TMV−’L3°末端の第9番「1のTがAへ変換され
た変異体のr、1)NA)をp s t lで消化し、
RNAの3“末端部分に相当する4、54Kb4得た後
、精製した。2) Construction of pLM31 The full-length double-stranded cDNA (
No. 9 of the TMV-'L3° end (r of the mutant in which T in 1 was converted to A, 1) NA) was digested with p s t l,
After obtaining 4,54 Kb4 corresponding to the 3'' end portion of the RNA, it was purified.
これをpUC9の2.1IIKbのΔatll/Pst
lフラグメントおよびpUcG91の0.49KbのA
atll/フィルインM I u Iフラグメントを結
合した。 結合したDNAをE、coliMC1061
へ形質転換した。 コロニーハイブリディジョンおよび
制限酵素地図を作成し、第4図に示した構造のpLM3
1を選択した。This is Δatll/Pst of 2.1IIKb of pUC9.
l fragment and the 0.49 Kb A of pUcG91
The atll/fillin M I u I fragment was ligated. The combined DNA was transferred to E. coli MC1061.
transformed into. Colony hybridization and restriction enzyme maps were created and pLM3 with the structure shown in Figure 4 was created.
I chose 1.
3)pLFWlの構築
pLM31のPstlサイトに、pLM51のPstl
フラグメント(Pmプロモーターおよび5”末端を含む
。)を挿入することにより完全長cDNAを含むpLF
Wlを構築した。3) Construction of pLFWl Pstl of pLM51 is inserted into the Pstl site of pLM31.
pLF containing the full-length cDNA by inserting the fragment (including the Pm promoter and 5” end)
Wl was constructed.
pLFW3の構築
pLFWlのNcol/Apalフラグメントをp L
−1−13(Takamatsu et al、Nu
cleicAcids Res、 11.376−37
78 (1983) :約1 、600bpのTMV
−L株の3°末端の(、DNAを含む。)のNcol/
Apalフラグメントで、EcoR1/Ncolフラグ
メントをpLT7D27 (Ohno etal、:
J、 Biochem、96. 1915−1923
(1984):TMV−L株RNAの5”末端から
6215番までのcDNAを含む)のE c o RI
、/ N c 、o Iフラグメントで置換するごと
により第4図に示した構造のpLFW3がiiIられた
。Construction of pLFW3 The Ncol/Apal fragment of pLFWl was pL
-1-13 (Takamatsu et al, Nu
Cleic Acids Res, 11.376-37
78 (1983): approximately 1,600bp TMV
-Ncol/of the 3° end (containing DNA) of the L strain
The EcoR1/Ncol fragment was transformed into pLT7D27 (Ohno et al.:
J. Biochem, 96. 1915-1923
(1984): Eco RI of TMV-L strain RNA (containing cDNA from 5” end to position 6215)
, / N c , o I fragments resulted in pLFW3 having the structure shown in FIG.
pLFAlの構築
上記と同様にp l FW 1のl−Cc o RI
/ A p a IフラグメントをpLzΔ−八250
)EcoRT/Apalフラグメントで置換することに
よりTMV L++A株の完全M (: D N A
を3.11み込んだ転写ベクターpLFAIを横築した
。Construction of pLFAl As above, l-CcoRI of plFW1
/ A p a I fragment pLzΔ-8250
) of the TMV L++A strain by substitution with the EcoRT/Apal fragment (: DNA
A transcription vector pLFAI containing 3.11 was constructed horizontally.
第1図は、本発明の転写ベクターpCL29構築の概略
を示す図である。
図中Pmは、アールキストの開発したpPM1由来のλ
ファージのプロモーターを表す。
130に/180K、30におよびcpは、TMVの1
30に/180にタンパク遺伝子、30にタンパク遺伝
子およびコートタンパク遺伝子を表す。 その前後の四
角で囲んだ5および3は、それぞれ5°末端非翻訳領域
および3”末端非翻訳領域を表す。
第2図は、ユニバーサル転写ベクターp LDC329
構築の概要を表す図である。
第3図は、CAT遺伝子を含む転写ベクターpCL29
(pCL、B29) 、転写ベクターp LDC32
9およびTMV(7)RNA、+7)cDNAを組み込
んだ転写ベクターpLFW3のDNA構造を表す図であ
る。
第4図は、プラスミドpLM31.pLM51゜pLW
F 1、pLWF3、およびp−L−1−13のDNA
構造を表す図である。
第5図は、pUcG91、pLFWl、pLFW3のM
l u Iサイト周辺のDNA配列を表す図である。
第6図は、CATの発現を確認する実験におけるオート
ラジオグラフィーの結果を示す図である。
完
一25=
特fL’JR,VG3−14693 (9)l −
−H
d φ !
ω ■ Σ1「÷1
→−〉
藁
;
あ
旧
6諧 jを
第5図
pUcG91のM l u Iサイト周辺のDNA配列
pLFW1のMluIサイト周辺のDNA配列ApaI
Mlul
pLFW3のM 1 u Iサイト周辺のDNA配列A
paI MluI
第6図
1.3AcCm
0 0、 IAcCm
lAcCm000
0DO4567FIG. 1 is a diagram schematically showing the construction of the transcription vector pCL29 of the present invention. In the figure, Pm is λ derived from pPM1 developed by Ahlquist.
Represents the phage promoter. 130/180K, 30 and cp 1 of TMV
30/180 represents a protein gene, 30 represents a protein gene and a coat protein gene. 5 and 3 enclosed in squares before and after represent the 5° terminal untranslated region and the 3'' terminal untranslated region, respectively. Figure 2 shows the universal transcription vector pLDC329.
It is a diagram showing an outline of construction. Figure 3 shows transcription vector pCL29 containing the CAT gene.
(pCL, B29), transcription vector pLDC32
FIG. 9 is a diagram showing the DNA structure of transcription vector pLFW3 incorporating TMV (7) RNA and +7) cDNA. FIG. 4 shows plasmid pLM31. pLM51゜pLW
DNA of F 1, pLWF3, and p-L-1-13
FIG. Figure 5 shows the M of pUcG91, pLFWl, pLFW3.
FIG. 2 is a diagram showing the DNA sequence around the l u I site. FIG. 6 is a diagram showing the results of autoradiography in an experiment to confirm the expression of CAT. Kanichi 25 = special fL'JR, VG3-14693 (9) l - -H d φ! ω ■ Σ1 "÷ 1 → ->Straw; Old 6th scale j Fig. 5 DNA sequence around the Mlu I site of pUcG91 DNA sequence around the Mlu I site of pLFW1 ApaI
DNA sequence A around the M 1 u I site of Mlul pLFW3
paI MluI Figure 6 1.3AcCm 0 0, IAcCm lAcCm000 0DO4567
Claims (7)
域を外来遺伝子で置換することにより製造した植物RN
Aベクター(1) Plant RN produced by replacing the coat protein gene region of tobamovirus RNA with a foreign gene
A vector
域が外来遺伝子で置換された配列を有するトバモウイル
スRNAを転写産物とする転写ベクター(2) A transcription vector whose transcription product is tobamovirus RNA, which has a sequence in which the coat protein gene region of tobamovirus RNA is replaced with a foreign gene.
びコートタンパク遺伝子領域が外来遺伝子で置換された
配列のトバモウイルスRNAのcDNAからなり、該プ
ロモーターの転写開始ヌクレオチドが該cDNAの最初
のヌクレオチドであるように接続されている特許請求の
範囲第2項記載の転写ベクター(3) Consists of a tobamovirus RNA cDNA in which the replication initiation region, selection marker, promoter, and coat protein gene region are replaced with foreign genes, and connected so that the transcription initiation nucleotide of the promoter is the first nucleotide of the cDNA. The transcription vector according to claim 2
ことを特徴とする特許請求の範囲第2あるいは3項記載
の転写ベクター(4) The transcription vector according to claim 2 or 3, wherein the promoter is a λ phage promoter.
びコートタンパク遺伝子領域が外来遺伝子挿入のための
制限酵素切断部位へ変換された配列のトバモウイルスR
NAのcDNAから成り、該プロモーターの転写開始ヌ
クレオチドが該cDNAの最初のヌクレオチドであるよ
うに接続されているユニバーサル転写ベクター(5) Tobamovirus R with a sequence in which the replication initiation region, selection marker, promoter, and coat protein gene region have been converted into restriction enzyme cleavage sites for foreign gene insertion
A universal transcription vector consisting of a cDNA of NA, connected such that the transcription initiation nucleotide of the promoter is the first nucleotide of the cDNA.
第5項記載のユニバーサル転写ベクター(6) Universal transcription vector according to claim 5 specified as pLDCS29
域を外来遺伝子で置換することにより製造した植物RN
Aベクター、あるいは該植物RNAベクターを用い再構
成したウイルスを接種することを特徴とする植物細胞へ
外来遺伝子を組み込む方法(7) Plant RN produced by replacing the coat protein gene region of tobamovirus RNA with a foreign gene
A method for integrating a foreign gene into a plant cell, which comprises inoculating a virus reconstituted using the A vector or the plant RNA vector.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61158443A JPS6314693A (en) | 1986-07-04 | 1986-07-04 | Plant virus RNA vector |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61158443A JPS6314693A (en) | 1986-07-04 | 1986-07-04 | Plant virus RNA vector |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6314693A true JPS6314693A (en) | 1988-01-21 |
Family
ID=15671878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61158443A Pending JPS6314693A (en) | 1986-07-04 | 1986-07-04 | Plant virus RNA vector |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6314693A (en) |
Cited By (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866785A (en) * | 1988-02-26 | 1999-02-02 | Biosource Technologies, Inc. | Recombinant plant viral nucleic acids |
US5889191A (en) * | 1992-12-30 | 1999-03-30 | Biosource Technologies, Inc. | Viral amplification of recombinant messenger RNA in transgenic plants |
US5965794A (en) * | 1992-12-30 | 1999-10-12 | Biosource Technologies, Inc. | Viral amplification of recombinant messenger RNA in transgenic plants |
US5977438A (en) * | 1988-02-26 | 1999-11-02 | Biosource Technologies, Inc. | Production of peptides in plants as viral coat protein fusions |
US6054566A (en) * | 1988-02-26 | 2000-04-25 | Biosource Technologies, Inc. | Recombinant animal viral nucleic acids |
US6284492B1 (en) | 1988-02-26 | 2001-09-04 | Large Scale Biology Corporation | Recombinant animal viral nucleic acids |
US6660500B2 (en) | 1988-02-26 | 2003-12-09 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
US7033835B1 (en) | 1988-02-26 | 2006-04-25 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
WO2007020638A2 (en) | 2005-08-15 | 2007-02-22 | Evogene Ltd. | Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
WO2008010228A2 (en) | 2006-07-20 | 2008-01-24 | Yeda Research And Development Co. Ltd. | Photosyntheticorganisms and compositions and methods of generating same |
WO2008122980A2 (en) | 2007-04-09 | 2008-10-16 | Evogene Ltd. | Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants |
WO2009083958A2 (en) | 2007-12-27 | 2009-07-09 | Evogene Ltd. | Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
WO2010049897A2 (en) | 2008-10-30 | 2010-05-06 | Evogene Ltd. | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny |
WO2010076756A2 (en) | 2008-12-29 | 2010-07-08 | Evogene Ltd. | Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same |
WO2010100595A2 (en) | 2009-03-02 | 2010-09-10 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
US7906705B2 (en) | 2006-07-03 | 2011-03-15 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center | Polynucleotides and polypeptides encoded therefrom and methods of using same for increasing biomass in plants and plants generated thereby |
WO2011048600A1 (en) | 2009-10-21 | 2011-04-28 | Danziger Innovations Ltd. | Generating genotypic variations in plant genomes by gamete infection |
EP2316950A1 (en) | 2000-03-27 | 2011-05-04 | Technion Research and Development Foundation, Ltd. | Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same |
WO2011067745A2 (en) | 2009-12-06 | 2011-06-09 | Rosetta Green Ltd. | Compositions and methods for enhancing plants resistance to abiotic stress |
EP2336330A2 (en) | 2004-06-14 | 2011-06-22 | Evogene Ltd. | Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
WO2011080674A2 (en) | 2009-12-28 | 2011-07-07 | Evogene Ltd. | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
WO2011099006A2 (en) | 2010-02-11 | 2011-08-18 | Yeda Research And Development Co. Ltd. | Enzymatic systems for carbon fixation and methods of generating same |
EP2365087A2 (en) | 2003-05-22 | 2011-09-14 | Evogene Ltd. | Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
EP2383345A1 (en) | 2006-12-20 | 2011-11-02 | Evogene Ltd. | Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
WO2011135527A2 (en) | 2010-04-28 | 2011-11-03 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
WO2011158242A2 (en) | 2010-06-16 | 2011-12-22 | Futuragene Israel Ltd. | Pest -resistant plants containing a combination of a spider toxin and a chitinase |
WO2012007945A2 (en) | 2010-07-12 | 2012-01-19 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center | Isolated polynucleotides and methods and plants using same for regulating plant acidity |
WO2012007919A2 (en) | 2010-07-15 | 2012-01-19 | Technion Research & Development Foundation Ltd. | Nucleic acid construct for increasing abiotic stress tolerance in plants |
WO2012032520A1 (en) | 2010-09-07 | 2012-03-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease |
EP2441840A1 (en) | 2005-07-18 | 2012-04-18 | Protalix Ltd. | Mucosal or enteral administration of biologically active macromolecules |
WO2012059922A2 (en) | 2010-11-03 | 2012-05-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Transgenic plants with improved saccharification yields and methods of generating same |
WO2012098537A1 (en) | 2011-01-20 | 2012-07-26 | Protalix Ltd. | Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
WO2012117406A2 (en) | 2011-03-02 | 2012-09-07 | Futuragene Israel Ltd. | Bacterial resistant transgenic plants |
WO2012156976A1 (en) | 2011-05-16 | 2012-11-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods of producing artemisinin in non-host plants and vectors for use in same |
EP2599790A1 (en) | 2007-11-26 | 2013-06-05 | Yissum Research Development Company of The Hebrew University of Jerusalem | Compositions comprising fibrous polypeptides and polysachharides |
WO2013088438A1 (en) | 2011-12-11 | 2013-06-20 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center | Methods of modulating stomata conductance and plant expression constructs for executing same |
WO2013114373A1 (en) | 2012-02-01 | 2013-08-08 | Protalix Ltd. | Inhalable liquid formulations of dnase i |
WO2013121405A1 (en) | 2012-02-19 | 2013-08-22 | Protalix Ltd. | Oral unit dosage forms and uses of same for the treatment of gaucher disease |
WO2014033723A1 (en) | 2012-09-03 | 2014-03-06 | A.B. Seeds Ltd. | Method of improving abiotic stress tolerance of plants and plants generated thereby |
EP2716654A1 (en) | 2005-10-24 | 2014-04-09 | Evogene Ltd. | Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same |
WO2014136117A1 (en) | 2013-03-06 | 2014-09-12 | Protalix Ltd. | USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN THERAPY |
WO2014136114A1 (en) | 2013-03-06 | 2014-09-12 | Protalix Ltd. | TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME |
EP2816117A2 (en) | 2004-09-29 | 2014-12-24 | Collplant Ltd. | Collagen producing plants and methods of generating and using same |
WO2015118547A1 (en) | 2014-02-10 | 2015-08-13 | Protalix Ltd. | Method of maintaining disease stability in a subject having gaucher's disease |
EP2910638A2 (en) | 2007-07-24 | 2015-08-26 | Evogene Ltd. | Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same |
EP2936976A1 (en) | 2008-04-21 | 2015-10-28 | Danziger Innovations Ltd. | Plant viral expression vectors and use of same for generating genotypic variations in plant genomes |
EP3020410A1 (en) | 2008-04-18 | 2016-05-18 | Collplant Ltd. | Methods of generating and using procollagen |
WO2016079739A2 (en) | 2014-11-20 | 2016-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells |
WO2016084084A1 (en) | 2014-11-27 | 2016-06-02 | Danziger Innovations Ltd. | Nucleic acid constructs for genome editing |
EP3072972A2 (en) | 2008-08-18 | 2016-09-28 | Evogene Ltd. | Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants |
WO2017125931A1 (en) | 2016-01-21 | 2017-07-27 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Parthenocarpic plants and methods of producing same |
EP3238534A2 (en) | 2009-06-10 | 2017-11-01 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance |
WO2018220581A1 (en) | 2017-05-31 | 2018-12-06 | Tropic Biosciences UK Limited | Compositions and methods for increasing shelf-life of banana |
WO2018220579A1 (en) | 2017-05-31 | 2018-12-06 | Tropic Biosciences UK Limited | Compositions and methods for increasing extractability of solids from coffee beans |
WO2018220582A1 (en) | 2017-05-31 | 2018-12-06 | Tropic Biosciences UK Limited | Methods of selecting cells comprising genome editing events |
WO2018224861A1 (en) | 2017-06-07 | 2018-12-13 | International Rice Research Institute | Increasing hybrid seed production through higher outcrossing rate in cytoplasmic male sterile gramineae plants and related materials and methods |
WO2019106638A1 (en) | 2017-12-03 | 2019-06-06 | Seedx Technologies Inc. | Systems and methods for sorting of seeds |
WO2019211854A1 (en) | 2018-05-03 | 2019-11-07 | Collplant Holdings Ltd. | Dermal fillers and applications thereof |
WO2019211750A1 (en) | 2018-05-01 | 2019-11-07 | Tropic Biosciences UK Limited | Compositions and methods for reducing caffeine content in coffee beans |
WO2019234750A1 (en) | 2018-06-07 | 2019-12-12 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Methods of regenerating and transforming cannabis |
WO2019234754A1 (en) | 2018-06-07 | 2019-12-12 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Nucleic acid constructs and methods of using same |
WO2020183416A1 (en) | 2019-03-14 | 2020-09-17 | Tropic Biosciences UK Limited | PRODUCTION OF dsRNA IN PLANT CELLS FOR PEST PROTECTION VIA GENE SILENCING |
WO2020183419A1 (en) | 2019-03-14 | 2020-09-17 | Tropic Biosciences UK Limited | Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest |
WO2020183414A2 (en) | 2019-03-14 | 2020-09-17 | Tropic Biosciences UK Limited | Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells |
WO2021001784A1 (en) | 2019-07-04 | 2021-01-07 | Ukko Inc. | De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity |
WO2021019536A1 (en) | 2019-07-30 | 2021-02-04 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby |
WO2021100034A1 (en) | 2019-11-19 | 2021-05-27 | Protalix Ltd. | Removal of constructs from transformed cells |
WO2021202513A1 (en) | 2020-03-31 | 2021-10-07 | Elo Life Systems | Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits |
WO2022038536A1 (en) | 2020-08-18 | 2022-02-24 | International Rice Research Institute | Methods of increasing outcrossing rates in gramineae |
WO2022074646A1 (en) | 2020-10-05 | 2022-04-14 | Protalix Ltd. | Dicer-like knock-out plant cells |
WO2022087527A1 (en) | 2020-10-23 | 2022-04-28 | Elo Life Systems, Inc. | Methods for producing vanilla plants with improved flavor and agronomic production |
WO2022115498A1 (en) | 2020-11-26 | 2022-06-02 | Ukko Inc. | Modified high molecular weight glutenin subunit and uses thereof |
WO2022226316A1 (en) | 2021-04-22 | 2022-10-27 | Precision Biosciences, Inc. | Compositions and methods for generating male sterile plants |
EP4170029A2 (en) | 2017-09-19 | 2023-04-26 | Tropic Biosciences UK Limited | Modifying the specifity of plant non-coding rna molecules for silencing gene expression |
-
1986
- 1986-07-04 JP JP61158443A patent/JPS6314693A/en active Pending
Cited By (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6660500B2 (en) | 1988-02-26 | 2003-12-09 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
US7192740B2 (en) | 1988-02-26 | 2007-03-20 | Large Scale Biology Corporation | Recombinant viral nucleic acids |
US5889190A (en) * | 1988-02-26 | 1999-03-30 | Biosource Technologies, Inc. | Recombinant plant viral nucleic acids |
US5866785A (en) * | 1988-02-26 | 1999-02-02 | Biosource Technologies, Inc. | Recombinant plant viral nucleic acids |
US5977438A (en) * | 1988-02-26 | 1999-11-02 | Biosource Technologies, Inc. | Production of peptides in plants as viral coat protein fusions |
US6054566A (en) * | 1988-02-26 | 2000-04-25 | Biosource Technologies, Inc. | Recombinant animal viral nucleic acids |
US6284492B1 (en) | 1988-02-26 | 2001-09-04 | Large Scale Biology Corporation | Recombinant animal viral nucleic acids |
US7033835B1 (en) | 1988-02-26 | 2006-04-25 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
US5965794A (en) * | 1992-12-30 | 1999-10-12 | Biosource Technologies, Inc. | Viral amplification of recombinant messenger RNA in transgenic plants |
US6852846B2 (en) | 1992-12-30 | 2005-02-08 | Large Scale Biology Corporation | Viral amplification of recombinant messenger RNA in transgenic plants |
US6462255B1 (en) | 1992-12-30 | 2002-10-08 | Large Scale Biology Corporation | Viral amplification of recombinant messenger RNA in transgenic plants |
US5889191A (en) * | 1992-12-30 | 1999-03-30 | Biosource Technologies, Inc. | Viral amplification of recombinant messenger RNA in transgenic plants |
EP2316950A1 (en) | 2000-03-27 | 2011-05-04 | Technion Research and Development Foundation, Ltd. | Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same |
EP2365087A2 (en) | 2003-05-22 | 2011-09-14 | Evogene Ltd. | Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
EP2343373A1 (en) | 2004-06-14 | 2011-07-13 | Evogene Ltd. | Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
EP2336330A2 (en) | 2004-06-14 | 2011-06-22 | Evogene Ltd. | Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
EP3088528A1 (en) | 2004-09-29 | 2016-11-02 | Collplant Ltd. | Collagen producing plants and methods of generating and using same |
EP2816117A2 (en) | 2004-09-29 | 2014-12-24 | Collplant Ltd. | Collagen producing plants and methods of generating and using same |
EP2484768A2 (en) | 2005-07-18 | 2012-08-08 | Protalix Ltd. | Mucosal or enteral administration of biologically active macromolecules |
EP2441840A1 (en) | 2005-07-18 | 2012-04-18 | Protalix Ltd. | Mucosal or enteral administration of biologically active macromolecules |
EP2995194A1 (en) | 2005-08-15 | 2016-03-16 | Evogene Ltd. | Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
WO2007020638A2 (en) | 2005-08-15 | 2007-02-22 | Evogene Ltd. | Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
EP2716654A1 (en) | 2005-10-24 | 2014-04-09 | Evogene Ltd. | Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same |
US7906705B2 (en) | 2006-07-03 | 2011-03-15 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center | Polynucleotides and polypeptides encoded therefrom and methods of using same for increasing biomass in plants and plants generated thereby |
WO2008010228A2 (en) | 2006-07-20 | 2008-01-24 | Yeda Research And Development Co. Ltd. | Photosyntheticorganisms and compositions and methods of generating same |
EP2383345A1 (en) | 2006-12-20 | 2011-11-02 | Evogene Ltd. | Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
WO2008122980A2 (en) | 2007-04-09 | 2008-10-16 | Evogene Ltd. | Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants |
EP2910638A2 (en) | 2007-07-24 | 2015-08-26 | Evogene Ltd. | Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same |
EP2599790A1 (en) | 2007-11-26 | 2013-06-05 | Yissum Research Development Company of The Hebrew University of Jerusalem | Compositions comprising fibrous polypeptides and polysachharides |
WO2009083958A2 (en) | 2007-12-27 | 2009-07-09 | Evogene Ltd. | Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
EP3020410A1 (en) | 2008-04-18 | 2016-05-18 | Collplant Ltd. | Methods of generating and using procollagen |
EP2936976A1 (en) | 2008-04-21 | 2015-10-28 | Danziger Innovations Ltd. | Plant viral expression vectors and use of same for generating genotypic variations in plant genomes |
EP3616504A2 (en) | 2008-08-18 | 2020-03-04 | Evogene Ltd. | Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants |
EP3072972A2 (en) | 2008-08-18 | 2016-09-28 | Evogene Ltd. | Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants |
WO2010049897A2 (en) | 2008-10-30 | 2010-05-06 | Evogene Ltd. | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny |
WO2010076756A2 (en) | 2008-12-29 | 2010-07-08 | Evogene Ltd. | Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same |
WO2010100595A2 (en) | 2009-03-02 | 2010-09-10 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
EP3000889A2 (en) | 2009-03-02 | 2016-03-30 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
EP3626051A2 (en) | 2009-06-10 | 2020-03-25 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance |
EP3238534A2 (en) | 2009-06-10 | 2017-11-01 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance |
WO2011048600A1 (en) | 2009-10-21 | 2011-04-28 | Danziger Innovations Ltd. | Generating genotypic variations in plant genomes by gamete infection |
US9562235B2 (en) | 2009-12-06 | 2017-02-07 | A.B. Seeds Ltd. | MicroRNA compositions and methods for enhancing plant resistance to abiotic stress |
WO2011067745A2 (en) | 2009-12-06 | 2011-06-09 | Rosetta Green Ltd. | Compositions and methods for enhancing plants resistance to abiotic stress |
WO2011080674A2 (en) | 2009-12-28 | 2011-07-07 | Evogene Ltd. | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
WO2011099006A2 (en) | 2010-02-11 | 2011-08-18 | Yeda Research And Development Co. Ltd. | Enzymatic systems for carbon fixation and methods of generating same |
WO2011135527A2 (en) | 2010-04-28 | 2011-11-03 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
WO2011158242A2 (en) | 2010-06-16 | 2011-12-22 | Futuragene Israel Ltd. | Pest -resistant plants containing a combination of a spider toxin and a chitinase |
WO2012007945A2 (en) | 2010-07-12 | 2012-01-19 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center | Isolated polynucleotides and methods and plants using same for regulating plant acidity |
WO2012007919A2 (en) | 2010-07-15 | 2012-01-19 | Technion Research & Development Foundation Ltd. | Nucleic acid construct for increasing abiotic stress tolerance in plants |
WO2012032520A1 (en) | 2010-09-07 | 2012-03-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease |
WO2012059922A2 (en) | 2010-11-03 | 2012-05-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Transgenic plants with improved saccharification yields and methods of generating same |
WO2012098537A1 (en) | 2011-01-20 | 2012-07-26 | Protalix Ltd. | Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
WO2012117406A2 (en) | 2011-03-02 | 2012-09-07 | Futuragene Israel Ltd. | Bacterial resistant transgenic plants |
WO2012156976A1 (en) | 2011-05-16 | 2012-11-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods of producing artemisinin in non-host plants and vectors for use in same |
WO2013088438A1 (en) | 2011-12-11 | 2013-06-20 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center | Methods of modulating stomata conductance and plant expression constructs for executing same |
US9603907B2 (en) | 2012-02-01 | 2017-03-28 | Protalix Ltd. | Dry powder formulations of dNase I |
WO2013114374A1 (en) | 2012-02-01 | 2013-08-08 | Protalix Ltd. | Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy |
WO2013114373A1 (en) | 2012-02-01 | 2013-08-08 | Protalix Ltd. | Inhalable liquid formulations of dnase i |
WO2013114371A1 (en) | 2012-02-01 | 2013-08-08 | Protalix Ltd. | Dry powder formulations of dnase i |
US9603906B2 (en) | 2012-02-01 | 2017-03-28 | Protalix Ltd. | Inhalable liquid formulations of DNase I |
WO2013121405A1 (en) | 2012-02-19 | 2013-08-22 | Protalix Ltd. | Oral unit dosage forms and uses of same for the treatment of gaucher disease |
WO2014033723A1 (en) | 2012-09-03 | 2014-03-06 | A.B. Seeds Ltd. | Method of improving abiotic stress tolerance of plants and plants generated thereby |
WO2014136113A1 (en) | 2013-03-06 | 2014-09-12 | Protalix Ltd. | Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same |
WO2014136114A1 (en) | 2013-03-06 | 2014-09-12 | Protalix Ltd. | TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME |
WO2014136117A1 (en) | 2013-03-06 | 2014-09-12 | Protalix Ltd. | USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN THERAPY |
WO2015118547A1 (en) | 2014-02-10 | 2015-08-13 | Protalix Ltd. | Method of maintaining disease stability in a subject having gaucher's disease |
WO2016079739A2 (en) | 2014-11-20 | 2016-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells |
WO2016084084A1 (en) | 2014-11-27 | 2016-06-02 | Danziger Innovations Ltd. | Nucleic acid constructs for genome editing |
WO2017125931A1 (en) | 2016-01-21 | 2017-07-27 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Parthenocarpic plants and methods of producing same |
WO2018220582A1 (en) | 2017-05-31 | 2018-12-06 | Tropic Biosciences UK Limited | Methods of selecting cells comprising genome editing events |
WO2018220579A1 (en) | 2017-05-31 | 2018-12-06 | Tropic Biosciences UK Limited | Compositions and methods for increasing extractability of solids from coffee beans |
WO2018220581A1 (en) | 2017-05-31 | 2018-12-06 | Tropic Biosciences UK Limited | Compositions and methods for increasing shelf-life of banana |
EP4461813A2 (en) | 2017-05-31 | 2024-11-13 | Tropic Biosciences UK Limited | Compositions and methods for increasing shelf-life of banana |
WO2018224861A1 (en) | 2017-06-07 | 2018-12-13 | International Rice Research Institute | Increasing hybrid seed production through higher outcrossing rate in cytoplasmic male sterile gramineae plants and related materials and methods |
EP4170029A2 (en) | 2017-09-19 | 2023-04-26 | Tropic Biosciences UK Limited | Modifying the specifity of plant non-coding rna molecules for silencing gene expression |
WO2019106638A1 (en) | 2017-12-03 | 2019-06-06 | Seedx Technologies Inc. | Systems and methods for sorting of seeds |
WO2019211750A1 (en) | 2018-05-01 | 2019-11-07 | Tropic Biosciences UK Limited | Compositions and methods for reducing caffeine content in coffee beans |
WO2019211854A1 (en) | 2018-05-03 | 2019-11-07 | Collplant Holdings Ltd. | Dermal fillers and applications thereof |
US11801329B2 (en) | 2018-05-03 | 2023-10-31 | Collplant Ltd. | Dermal fillers and applications thereof |
EP4446363A2 (en) | 2018-05-03 | 2024-10-16 | CollPlant Ltd. | Dermal fillers and applications thereof |
US12186449B2 (en) | 2018-05-03 | 2025-01-07 | Collplant Ltd. | Dermal fillers and applications thereof |
WO2019234750A1 (en) | 2018-06-07 | 2019-12-12 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Methods of regenerating and transforming cannabis |
WO2019234754A1 (en) | 2018-06-07 | 2019-12-12 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Nucleic acid constructs and methods of using same |
WO2020183414A2 (en) | 2019-03-14 | 2020-09-17 | Tropic Biosciences UK Limited | Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells |
WO2020183419A1 (en) | 2019-03-14 | 2020-09-17 | Tropic Biosciences UK Limited | Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest |
WO2020183416A1 (en) | 2019-03-14 | 2020-09-17 | Tropic Biosciences UK Limited | PRODUCTION OF dsRNA IN PLANT CELLS FOR PEST PROTECTION VIA GENE SILENCING |
WO2021001784A1 (en) | 2019-07-04 | 2021-01-07 | Ukko Inc. | De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity |
WO2021019536A1 (en) | 2019-07-30 | 2021-02-04 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby |
WO2021100034A1 (en) | 2019-11-19 | 2021-05-27 | Protalix Ltd. | Removal of constructs from transformed cells |
WO2021202513A1 (en) | 2020-03-31 | 2021-10-07 | Elo Life Systems | Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits |
WO2022038536A1 (en) | 2020-08-18 | 2022-02-24 | International Rice Research Institute | Methods of increasing outcrossing rates in gramineae |
WO2022074646A1 (en) | 2020-10-05 | 2022-04-14 | Protalix Ltd. | Dicer-like knock-out plant cells |
WO2022087527A1 (en) | 2020-10-23 | 2022-04-28 | Elo Life Systems, Inc. | Methods for producing vanilla plants with improved flavor and agronomic production |
WO2022115498A1 (en) | 2020-11-26 | 2022-06-02 | Ukko Inc. | Modified high molecular weight glutenin subunit and uses thereof |
WO2022226316A1 (en) | 2021-04-22 | 2022-10-27 | Precision Biosciences, Inc. | Compositions and methods for generating male sterile plants |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6314693A (en) | Plant virus RNA vector | |
Meshi et al. | In vitro transcription of infectious RNAs from full-length cDNAs of tobacco mosaic virus | |
US5846795A (en) | RNA transformation vector | |
US5162601A (en) | Plant potyvirus expression vector with a gene for protease | |
US5466788A (en) | Subgenomic promoter | |
Turpen et al. | Transfection of whole plants from wounds inoculated with Agrobacterium tumefaciens containing cDNA of tobacco mosaic virus | |
US5633447A (en) | Plant tissue comprising a subgenomic promoter | |
JPS61502166A (en) | Improved methods and vectors for transformation of plant cells | |
JPH0231683A (en) | Transfer activating element of t-dna 780 gene | |
US5443969A (en) | RNA packaging system | |
CN116064647B (en) | A plant virus expression vector and its application | |
US9085775B2 (en) | Artificial DNA sequence with optimized leader function in 5′ (5′-UTR) for the improved expression of heterologous proteins in plants | |
TWI480375B (en) | Glycosyltransferase promoter from a medicinal herb on gene regulation and application | |
Nagata et al. | Simplified methods for the construction of RNA and DNA virus infectious clones | |
JPH07501921A (en) | Photoactivatable plant promoters | |
US6664384B1 (en) | Duplicated cassava vein mosaic virus enhancers and uses thereof | |
Ahlquist | In vitro transcription of infectious viral RNA from cloned cDNA | |
CN109207510B (en) | Construction method of monocotyledon miRNA (micro ribonucleic acid) efficient silencing vector | |
US20150284738A1 (en) | Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants | |
KR100609565B1 (en) | Plant expression vector containing the whole genome mosaic virus | |
JPH0249591A (en) | plant virus RNA vector | |
CN110144364A (en) | Cre-LoxP recombination system for invasive cloning of pepper mild mottle virus and its application | |
RU2237717C2 (en) | Recombinant plasmid pgbp450f for preparing transgenic plants and method for preparing transgenic tobacco plants with enhanced productivity and resistance to fungal phytopathogens | |
CA1332718C (en) | Expression cassette for plants | |
JPH01120290A (en) | plant viral RNA vector |